United States · FDA National Drug Code directory
LISRAYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87211-030_4ea28f02-7a6c-4e71-86ba-8c516f6d9323
- Product NDC
- 87211-030
- Form
- TABLET, FILM COATED
- Composition / generic term
- brepocitinib
- Labeler
- Priovant Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260827
- Source listing expiry
- 20271231
Source-listed ingredients
- BREPOCITINIB TOSYLATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (87211-030-30) / 30 TABLET, FILM COATED in 1 BOTTLE · 87211-030-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →